Pharyngitis Newswire

Pharyngitis Newswire

Comprehensive Real-Time News Feed for Pharyngitis.

Results 1 - 4 of 4 in Pharyngitis

  1. Quidel Receives FDA Clearance for Its New Solana(TM) Molecular System ...Read the original story w/Photo

    Jun 23, 2015 | Market Wire

    ... pyogenes ) nucleic acids isolated from throat swab specimens from patients with signs and symptoms of pharyngitis, such as sore throat. The Solana molecular platform leverages the Helicase-Dependent Amplification (HDA) technology that is resident in ...

    Comment?

  2. Quidel Receives FDA Clearance for Its New Solana(TM) Molecular System ...Read the original story

    Jun 23, 2015 | Freshnews

    Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510 clearance from the United States Food and Drug Administration to market Quidel's new instrumented molecular system -- Solana -- and for the Solana Group A Strep Assay for the rapid, qualitative detection of I2-hemolytic, Group A Streptococcus nucleic acids isolated from throat swab specimens from patients with signs and symptoms of pharyngitis, such as sore throat. molecular product line to generate a fast and accurate test result.

    Comment?

  3. FDA Clears the Simplexa(TM) Group A Strep Direct Test from Focus...Read the original story

    Apr 15, 2015 | Freshnews

    ... bacteria directly from throat swabs. The most prevalent form of Group A Streptococcus (GAS) is strep throat (pharyngitis), a condition most common in children aged 5-15. More than 600 million cases of strep pharyngitis are estimated to occur ...

    Comment?

  4. Pharyngitis Global Clinical Trials Review, H2, 2013 - new market research report publishedRead the original story w/Photo

    Jan 11, 2015 | PR-inside.com

    This report provides elemental information and data relating to the clinical trials on Pharyngitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

    Comment?